Skip to content

Opening book details…

About this Economics, Econometrics and Finance article

Pnd7 Cost-effectiveness Of Cladribine Compared To Natalizumab, Ocrelizumab And Alemtuzumab For The Treatment Of Patients With Highly Active Relapsing Remitting Multiple Sclerosis In Chile by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R. is a Economics, Econometrics and Finance article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.

Author
Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.
Publisher
Elsevier ; Elsevier USA; Elsevier BV (ISSN 2212-1099)
Published
2019
Field
Economics, Econometrics and Finance (Social Sciences)

More by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.

Browse all works by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.